To the Editor—With great interest I read the article by Slifka et al [1] who reported convincing
evidence that performing regular booster vaccinations against diphtheria and tetanus in …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Background. A household contact substudy was performed as part of a prospective, cohort
pertussis vaccine efficacy trial in Germany. Design. Infants received four doses of either the …

Background: We estimated tetanus-diphtheria-acellular pertussis (Tdap) vaccine
effectiveness (VE) for preventing pertussis among adolescents during a statewide outbreak …

Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

The review is devoted to the analysis of pertussis incidence of children in the age group of 5–
7, as well as strategies of DTP immunization with the help of the drugs in foreign countries …

A new generation of recombinant acellular pertussis vaccine containing genetically
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …

BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …

抄録 Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is
generally used for booster vaccination of infants in Europe and the United States to avoid …